BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 9829617)

  • 41. [Effects of various physiologic adenine derivatives on the secretion of acid in isolated gastric glands in rabbits].
    Ainz LF; Gil-Rodrigo CE; Gómez R; Malillos M; Requejo D; Gandarias JM
    Rev Esp Fisiol; 1989 Sep; 45(3):281-6. PubMed ID: 2616875
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Purinergic receptors and pain.
    Burnstock G
    Curr Pharm Des; 2009; 15(15):1717-35. PubMed ID: 19442186
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Purinergic contribution to amyotrophic lateral sclerosis.
    Volonté C; Apolloni S; Parisi C; Amadio S
    Neuropharmacology; 2016 May; 104():180-93. PubMed ID: 26514402
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Purinoreceptors are involved in the control of acute morphine withdrawal.
    Capasso A; Loizzo A
    Life Sci; 2001 Sep; 69(18):2179-88. PubMed ID: 11669461
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The birth and postnatal development of purinergic signalling.
    Burnstock G; Fredholm BB; North RA; Verkhratsky A
    Acta Physiol (Oxf); 2010 Jun; 199(2):93-147. PubMed ID: 20345419
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Regulation of rhythmic movements by purinergic neurotransmitters in frog embryos.
    Dale N; Gilday D
    Nature; 1996 Sep; 383(6597):259-63. PubMed ID: 8805702
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Signaling by ATP receptors in astrocytes.
    Neary JT; Zhu Q
    Neuroreport; 1994 Aug; 5(13):1617-20. PubMed ID: 7819532
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evidence for P2-purinoceptor-mediated inhibition of noradrenaline release in rat brain cortex.
    von Kügelgen I; Späth L; Starke K
    Br J Pharmacol; 1994 Nov; 113(3):815-22. PubMed ID: 7858872
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Short- and long-term (trophic) purinergic signalling.
    Burnstock G
    Philos Trans R Soc Lond B Biol Sci; 2016 Aug; 371(1700):. PubMed ID: 27377731
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [New targets for drug therapeutics: receptors for purines and pyrimidines].
    Ren LM; Zhang M; Yao SK; Zhu ZN
    Sheng Li Ke Xue Jin Zhan; 2003 Apr; 34(2):116-20. PubMed ID: 12889142
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The P2 receptors in platelet function.
    Hechler B; Cattaneo M; Gachet C
    Semin Thromb Hemost; 2005 Apr; 31(2):150-61. PubMed ID: 15852218
    [TBL] [Abstract][Full Text] [Related]  

  • 52. P2Y13 receptors mediate presynaptic inhibition of acetylcholine release induced by adenine nucleotides at the mouse neuromuscular junction.
    Guarracino JF; Cinalli AR; Fernández V; Roquel LI; Losavio AS
    Neuroscience; 2016 Jun; 326():31-44. PubMed ID: 27058149
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Overview of the P2 receptors.
    Boeynaems JM; Communi D; Gonzalez NS; Robaye B
    Semin Thromb Hemost; 2005 Apr; 31(2):139-49. PubMed ID: 15852217
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differential regulation of atrial contraction by P1 and P2 purinoceptors in normotensive and spontaneously hypertensive rats.
    Rodrigues JQ; da Silva ED; de Magalhães Galvão K; Miranda-Ferreira R; Caricati-Neto A; Jurkiewicz NH; Garcia AG; Jurkiewicz A
    Hypertens Res; 2014 Mar; 37(3):210-9. PubMed ID: 24285249
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Functional evidence that ATP or a related purine is an inhibitory NANC neurotransmitter in the mouse jejunum: study on the identity of P2X and P2Y purinoceptors involved.
    De Man JG; De Winter BY; Seerden TC; De Schepper HU; Herman AG; Pelckmans PA
    Br J Pharmacol; 2003 Nov; 140(6):1108-16. PubMed ID: 14530212
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Introduction: P2 receptors.
    Burnstock G
    Curr Top Med Chem; 2004; 4(8):793-803. PubMed ID: 15078211
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Balance of purines may determine life or death of retinal ganglion cells as A3 adenosine receptors prevent loss following P2X7 receptor stimulation.
    Zhang X; Zhang M; Laties AM; Mitchell CH
    J Neurochem; 2006 Jul; 98(2):566-75. PubMed ID: 16805847
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sympathoinhibition by adenosine A(1) receptors, but not P2 receptors, in the hamster mesenteric arterial bed.
    Ralevic V
    Eur J Pharmacol; 2000 Jan; 387(3):287-93. PubMed ID: 10650174
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Purinergic receptors in microglia: functional modal shifts of microglia mediated by P2 and P1 receptors.
    Koizumi S; Ohsawa K; Inoue K; Kohsaka S
    Glia; 2013 Jan; 61(1):47-54. PubMed ID: 22674620
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Extracellular nucleotides as novel, underappreciated pro-metastatic factors that stimulate purinergic signaling in human lung cancer cells.
    Schneider G; Glaser T; Lameu C; Abdelbaset-Ismail A; Sellers ZP; Moniuszko M; Ulrich H; Ratajczak MZ
    Mol Cancer; 2015 Nov; 14():201. PubMed ID: 26597723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.